Pharma Mar (Spain) Market Value
| PHM Stock | EUR 75.50 0.10 0.13% |
| Symbol | Pharma |
Pharma Mar 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharma Mar's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharma Mar.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Pharma Mar on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Pharma Mar SA or generate 0.0% return on investment in Pharma Mar over 30 days. Pharma Mar is related to or competes with Laboratorios Farmaceuticos, Atrys Health, and Oryzon Genomics. Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer dru... More
Pharma Mar Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharma Mar's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharma Mar SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.31 | |||
| Information Ratio | 0.199 | |||
| Maximum Drawdown | 38.62 | |||
| Value At Risk | (2.40) | |||
| Potential Upside | 4.75 |
Pharma Mar Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharma Mar's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharma Mar's standard deviation. In reality, there are many statistical measures that can use Pharma Mar historical prices to predict the future Pharma Mar's volatility.| Risk Adjusted Performance | 0.1823 | |||
| Jensen Alpha | 0.998 | |||
| Total Risk Alpha | 0.3151 | |||
| Sortino Ratio | 0.3862 | |||
| Treynor Ratio | 8.88 |
Pharma Mar SA Backtested Returns
Pharma Mar is very steady given 3 months investment horizon. Pharma Mar SA maintains Sharpe Ratio (i.e., Efficiency) of 0.24, which implies the firm had a 0.24% return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.06% are justified by taking the suggested risk. Use Pharma Mar Risk Adjusted Performance of 0.1823, coefficient of variation of 439.23, and Semi Deviation of 1.35 to evaluate company specific risk that cannot be diversified away. Pharma Mar holds a performance score of 18 on a scale of zero to a hundred. The company holds a Beta of 0.11, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pharma Mar's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharma Mar is expected to be smaller as well. Use Pharma Mar treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to analyze future returns on Pharma Mar.
Auto-correlation | -0.08 |
Very weak reverse predictability
Pharma Mar SA has very weak reverse predictability. Overlapping area represents the amount of predictability between Pharma Mar time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharma Mar SA price movement. The serial correlation of -0.08 indicates that barely 8.0% of current Pharma Mar price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 6.64 |
Pharma Mar SA lagged returns against current returns
Autocorrelation, which is Pharma Mar stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharma Mar's stock expected returns. We can calculate the autocorrelation of Pharma Mar returns to help us make a trade decision. For example, suppose you find that Pharma Mar has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharma Mar regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharma Mar stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharma Mar stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharma Mar stock over time.
Current vs Lagged Prices |
| Timeline |
Pharma Mar Lagged Returns
When evaluating Pharma Mar's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharma Mar stock have on its future price. Pharma Mar autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharma Mar autocorrelation shows the relationship between Pharma Mar stock current value and its past values and can show if there is a momentum factor associated with investing in Pharma Mar SA.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pharma Stock
Pharma Mar financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.